Evidence map›Paper›PMID 41069925›Full record

ArticleCureus2025

Multi-modal Malignancies in Cowden Syndrome: Diagnostic Challenges in a Suspected Case From a Low-Resource Setting.

Jawayria Sajid, Rohma Qureshi, Hamza Ahmad, Asad Ur Rehman Qureshi, Ahsan Shafiq

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jawayria SajidMedical Oncology, Shalamar Medical and Dental College, Lahore, PAK.
Rohma QureshiGeneral Medicine, Shalamar Institute of Health Sciences, Lahore, PAK.
Hamza AhmadGeneral Surgery, Shalamar Institute of Health Sciences, Lahore, PAK.
Asad Ur Rehman QureshiOtolaryngology - Head and Neck Surgery, Combined Military Hospital, Okara, PAK.
Ahsan ShafiqSurgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cowden syndrome (CS), a rare autosomal dominant disorder caused by mutations in the PTEN tumor suppressor gene, predisposes individuals to a wide range of malignancies, including breast, thyroid, endometrial, and renal cancers. This report presents a case of a 69-year-old woman with a history of papillary thyroid carcinoma, recently diagnosed invasive ductal carcinoma of the breast, and incidental clear cell renal cell carcinoma (RCC) - clinically pointing toward the diagnosis of CS. Genetic testing and endoscopic evaluations were not possible, as the case occurred in the setting of a developing country, with limited resources and financial constraints. This case underscores the importance of early recognition of hereditary cancer syndromes in patients with multiple malignancies, as well as the need for comprehensive genetic counseling, surveillance, and tailored treatment strategies. A multidisciplinary approach involving oncology, surgery, radiology, and genetics is crucial in managing the complex clinical presentation of patients with CS. The case also highlights the challenges faced when establishing a formal diagnosis in resource-constrained settings. These challenges are related not only to limited resources, but also to patient compliance, health literacy, and access to healthcare services.

Indexed as

breast cancercowden syndromehereditary cancer syndromeslow-middle income countrylow-resource settingmultiple primary tumorspapillary thyroid carcinomapten mutationrenal cell carcinoma

Identifiers

PMID41069925
PMCPMC12506589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.